Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely bentoquatam 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Ammonium lactate 1% lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely urea 100 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Betamethasone 0.1% lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely coal tar 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely salicylic acid 20 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely aluminium acetate 6.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Sulfacetamide 10% lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Hydrocortisone 2% topical lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely hydrocortisone 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely selenium sulfide 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely urea 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Hydrocortisone 2.5% lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely hydrocortisone 10 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Betamethasone dipropionate 0.05% lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely fludroxycortide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely methoxsalen 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely amcinonide 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely triamcinolone acetonide 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzyl alcohol 50 microliter/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely hydrocortisone butyrate 1 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely malathion 5 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely carbaryl 5 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely tetracycline 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely ciclopirox (as ciclopirox olamine) 7.7 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely hydrocortisone acetate 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely coal tar 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone valerate 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely coal tar 40 milligram/1 milliliter and ketoconazole 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely lindane 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely urea 100 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely hydrocortisone 10 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely salicylic acid 20 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely coal tar 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely coal tar 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely salicylic acid 20 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely hydrocortisone 10 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely coal tar 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely urea 100 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely coal tar 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely urea 100 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely salicylic acid 20 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely hydrocortisone 10 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion |
Inferred relationship |
Existential restriction modifier |
|